ABRAXANE

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug ABRAXANE contains one active pharmaceutical ingredient (API):

1 Paclitaxel albumin
UNII P88XT4IS4D - PACLITAXEL

Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability results in the inhibition of the normal dynamic reorganisation of the microtubule network that is essential for vital interphase and mitotic cellular functions.

Read about Paclitaxel

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ABRAXANE Powder for suspension for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01CD01 Paclitaxel L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes
Discover more medicines within L01CD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10150F, 10165B, 4531L, 7270P
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 562417080000007
Country: CA Health Products and Food Branch Identifier(s): 02281066
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 299-MEE-0514
Country: EE Ravimiamet Identifier(s): 1342998, 1636309
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 07428001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 397641
Country: FR Base de données publique des médicaments Identifier(s): 68739019
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 201590
Country: HK Department of Health Drug Office Identifier(s): 62459
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7936
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1032063, 1072784
Country: NL Z-Index G-Standaard Identifier(s): 15690172
Country: NL Z-Index G-Standaard, PRK Identifier(s): 98957
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 14039
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100265356
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69520001
Country: SG Health Sciences Authority Identifier(s): 14532P
Country: US FDA, National Drug Code Identifier(s): 68817-134
Country: ZA Health Products Regulatory Authority Identifier(s): 50/26/0182

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.